Last updated on July 2020

Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth

Brief description of study

The current study investigates the feasibility and safety of allogeneic mesenchymal stem/stromal cells in previous oropharynx cancer patients with radiation-induced hyposalivation and xerostomia

Detailed Study Description

Hyposalivation and xerostomia are the most common long-term side effects to radiotherapy of head and neck cancers.

A randomized clinical trial indicates that autologeous mesenchymal stem/stromal cells can restore function of the submandibular glands.

Patients with previous oropharynx cancer and radiation-induced hyposalivation and xerostomia will be treated with culture expanded adipose tissue derived mesenchymal stem/stromal cells from healthy donors.

The patients will be followed for 4 months for safety and efficacy registration

Clinical Study Identifier: NCT03874572

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.